Armand Bankhead 3rd
Overview
Explore the profile of Armand Bankhead 3rd including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
1252
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Frank S, Persse T, Coleman I, Bankhead 3rd A, Li D, De-Sarkar N, et al.
bioRxiv
. 2024 Jul;
PMID: 39071291
Genomic loss of the transcriptional kinase occurs in ~6% of metastatic castration-resistant prostate cancers (mCRPC) and correlates with poor patient outcomes. Prior studies demonstrate that acute CDK12 loss confers a...
2.
Xu Y, Xue D, Kyani A, Bankhead 3rd A, Roy J, Ljungman M, et al.
ACS Pharmacol Transl Sci
. 2023 Aug;
6(8):1164-1181.
PMID: 37588763
Pancreatic cancer cells adapt to nutrient-scarce metabolic conditions by increasing their oxidative phosphorylation reserve to survive. Here, we present a first-in-class small-molecule NDUFS7 antagonist that inhibits oxidative phosphorylation (OXPHOS) for...
3.
Kumaraswamy A, Duan Z, Flores D, Zhang C, Sehrawat A, Hu Y, et al.
JCI Insight
. 2023 Jul;
8(15).
PMID: 37440313
Lysine-specific demethylase 1 (LSD1) is a histone demethylase that promotes stemness and cell survival in cancers such as prostate cancer. Most prostate malignancies are adenocarcinomas with luminal differentiation. However, some...
4.
Kim D, Sun D, Storck W, Welker Leng K, Jenkins C, Coleman D, et al.
Clin Cancer Res
. 2021 Jun;
27(17):4923-4936.
PMID: 34145028
Purpose: Lineage plasticity in prostate cancer-most commonly exemplified by loss of androgen receptor (AR) signaling and a switch from a luminal to alternate differentiation program-is now recognized as a treatment...
5.
Cuthbertson C, Arabzada Z, Bankhead 3rd A, Kyani A, Neamati N
ACS Pharmacol Transl Sci
. 2021 Apr;
4(2):624-646.
PMID: 33860190
Metabolic reprogramming is a key hallmark of cancer and shifts cellular metabolism to meet the demands of biomass production necessary for abnormal cell reproduction. One-carbon metabolism (1CM) contributes to many...
6.
Xu Y, Xue D, Bankhead 3rd A, Neamati N
J Med Chem
. 2020 Oct;
63(23):14276-14307.
PMID: 33103432
Certain subtypes of cancer cells require oxidative phosphorylation (OXPHOS) to survive. Increased OXPHOS dependency is frequently a hallmark of cancer stem cells and cells resistant to chemotherapy and targeted therapies....
7.
Xu Y, Bankhead 3rd A, Tian X, Tang J, Ljungman M, Neamati N
Cancer Res
. 2020 Jun;
80(17):3692-3705.
PMID: 32571799
GST omega 1 (GSTO1) is an atypical GST isoform that is overexpressed in several cancers and has been implicated in drug resistance. Currently, no small-molecule drug targeting GSTO1 is under...
8.
Bankhead 3rd A, Mancini E, Sims A, Baric R, McWeeney S, Sloot P
Procedia Comput Sci
. 2020 Apr;
4:1798-1807.
PMID: 32288900
Virus infection is a complex biological phenomenon for which experiments provide a uniquely concise view where data is often obtained from a single population of cells, under controlled environmental conditions....
9.
Shergalis A, Hu S, Bankhead 3rd A, Neamati N
Pharmacol Ther
. 2020 Mar;
210:107525.
PMID: 32201313
Protein folding in the endoplasmic reticulum is an oxidative process that relies on protein disulfide isomerase (PDI) and endoplasmic reticulum oxidase 1 (ERO1). Over 30% of proteins require the chaperone...
10.
Bankhead 3rd A, McMaster T, Wang Y, Boonstra P, Palmbos P
EBioMedicine
. 2020 Jan;
51:102561.
PMID: 31927310
Background: Half of muscle-invasive bladder cancer patients will relapse with metastatic disease and molecular tests to predict relapse are needed. TP63 has been proposed as a prognostic biomarker in bladder...